(5-METHYL-1,2,4-OXADIAZOL-3-YL)ACETIC ACID, 95.0%, 1g

Hafnium(IV) Trifluoromethanesulfonate>90.0%(T)5g

ACETIC ACID, 2-(3-HYDROXYPROPOXY)-, ETHYL ESTER, 97%, 250mg

3-ACETYL-4-CHLORO-7-AZAINDOLE, 95.0%, 1g

N-Benzyl-2,2,2-trifluoroethanamine hydrochloride, 95%, 1g

4,6-Dichloro-2,5-dimethylpyrimidine, 95.0%, 1g

Ethyl 3-amino-3-iminopropanoate hydrochloride, 95.0%, 5g

GC capillary column ROTI®Cap-1, 20 m, 0.10 mm, 0.10 µm, 1 Piece(s)

4-Pyridin-2-ylbenzoic acid, 97.0%, 5g

2-(Hexadecyloxy)ethanol, 97%, 250mg

2-Chloro-4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]pyrimidine, 95%, 1g

4-(S-Methylsulfonimidoyl)phenol, 95%, 1g

2-{4-[(E)-(2-mercapto-4-oxo-1,3-thiazol-5(4H)-ylidene)methyl]phenoxy}acetamide, 90.0%, 1g